Greasing the way: the ABCs of HSPC efflux from the marrow

Benjamin T Suratt1, Michael B Fessler

  • 1Vermont Lung Center, University of Vermont College of Medicine, Burlington, VT 05405, USA.

Cell Stem Cell
|August 7, 2012
PubMed

Insights

Cholesterol moving through spleen cells controls the release of blood stem cells from bone marrow. This discovery offers new therapeutic strategies for blood disorders and atherosclerosis.

Area of Science:

  • Hematology
  • Cell Biology
  • Metabolic Regulation

Background:

  • Hematopoietic stem cell (HSC) mobilization is crucial for bone marrow regeneration and is influenced by various physiological and pathological factors.
  • Cholesterol metabolism plays a vital role in cellular function, but its specific role in HSC mobilization remains incompletely understood.

Discussion:

  • This study reveals that cholesterol flux within splenic phagocytes is a key regulator of hematopoietic stem and multipotential progenitor (HSPC) cell release from the bone marrow.
  • The findings highlight a novel mechanism linking lipid metabolism to stem cell trafficking and bone marrow homeostasis.

Key Insights:

  • Cholesterol transport via splenic phagocytes directly impacts the number of circulating HSPCs.
  • Disruptions in splenic cholesterol regulation can lead to altered stem cell availability.

Outlook:

  • These insights open new therapeutic avenues for treating myeloproliferative disorders by modulating stem cell mobilization.
  • Targeting cholesterol flux in phagocytes may offer novel strategies for managing atherosclerosis progression.

Related Concept Videos